OrthoDx is an Australian company established by doctors for doctors, with a commitment to changing the future of orthopaedic diagnostics through genomics. Using proprietary biomarkers and existing PCR technology, OrthoDx has developed Synvichor™, a world-first genomic PCR test that is able to differentiate between infectious and non-infectious joint pain in a matter of hours.OrthoDx have harnessed the power of the human immune system to translate key clinical information about the body's response to infection, rapidly and reliably.